ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Announces Neutron Therapy RFP Available

January 19, 1979

ASCO Updates Guideline On Use Of Tumor Markers

October 27, 2006

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

UNM Cancer Center Appoints Four Leaders

May 24, 2013

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010